The FDA has released a statement on the investigations into the presence of nitrosamines in some drugs; highlighting that there are currently no recalls of metformin within the US.
List view / Grid view
angiotensin II receptor blockers (ARBs)
Filter the results
Torrent Pharmaceuticals has received a warning letter from the FDA for violating cGMP regulations at its manufacturing facility in India.
The examination of ARB drugs by the FDA will be extended to include other generics with similar manufacturing processes to identify impurities.